BridgeMD
New treatment option for Cerebral Palsy
Official title GO-PLAY - Early Family-Centered Intervention for Infants With High-Risk of Cerebral Palsy
ClinicalTrials.gov ID: NCT05883969
What this study is testing
- What it's testing
- Background. Early diagnosis of cerebral palsy (CP) is important to enable appropriate intervention at a time when neuroplasticity is at its highest.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 3 to 12
You may be able to join if
- Infants will be included in the intervention study, if they fulfil at least one of the requirements A or B: A. any two of the following:
- Neuroimaging predictive of a motor disability including the involvement of one or more of the following structures: sensori-motor cortex, basal...
- General Movement Assessment with absent fidgety GMs at fidgety age
- HINE scores \<57 at 3months or \<60 at 6months or \<63 at 9 months or \<66 at 12 months B. both of the following:
- Unilateral brain injury on neuroimaging (MRI or ultrasound) predictive of CP
You likely can't join if
- Infants with progressive or neurodegenerative disorders or genetic disorders not associated with CP
- Infants with other disability diagnoses e.g. Down Syndrome.
- children for whom neither parent is fluent in Danish.
See the full eligibility criteria
- Infants will be included in the intervention study, if they fulfil at least one of the requirements A or B: A. any two of the following:
- Neuroimaging predictive of a motor disability including the involvement of one or more of the following structures: sensori-motor cortex, basal ganglia, posterior limb of the internal capsule, pyramidal tracts.
- General Movement Assessment with absent fidgety GMs at fidgety age
- HINE scores \<57 at 3months or \<60 at 6months or \<63 at 9 months or \<66 at 12 months B. both of the following:
- Unilateral brain injury on neuroimaging (MRI or ultrasound) predictive of CP
- Clinical signs of asymmetry
- Infants with progressive or neurodegenerative disorders or genetic disorders not associated with CP
- Infants with other disability diagnoses e.g. Down Syndrome.
- children for whom neither parent is fluent in Danish.
The study team makes the final eligibility decision.
Where it's taking place
- Aalborg, Denmark
- Aarhus, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 3 months to 12 months. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aalborg, Denmark; Aarhus, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.